Table 5.

Clinical characteristics of seven non-survival operative patients with COVID-19 infection.

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7	No. (%)
Date of admission	Jan 12	Jan 13	Jan 14	Jan 15	Jan 15	Jan 20	Jan 27	NA
Age, years	34	55	63	48	55	83	77	NA
Sex, Female/male	Female	Male	Male	Female	Female	Male	Female	NA
Epidemiological history*	Yes	Yes	Yes	Yes	Yes	Yes	Yes	7 (100)
Comorbidities
Cardiovascular disease	No	Yes	No	No	Yes	Yes	Yes	4 (57·1)
Malignancy	Yes	Yes	Yes	Yes	No	No	No	4 (57·1)
Hypertension	No	Yes	No	No	No	Yes	Yes	3 (42·9)
Diabetes	No	No	No	Yes	No	No	No	1 (14·3)
Cerebrovascular disease	No	No	No	No	No	Yes	No	1 (14·3)
COPD	No	Yes	No	No	No	No	No	1 (14·3)
Date of surgery	Jan 16	Jan 23	Jan 17	Jan 19	Jan 17	Jan 22	Jan 30	NA
Surgical type	Pancreatoduo-denectomy	Total esophagectomy	Thoracoscopic lobectomy	Radical resection of rectal cancer	Thoracoscopic lobectomy	Artificial femoral head replacement	Total hip replacement	NA
Surgical time, min	377	240	379	200	195	150	110	NA
Date of first symptom or sign	Jan 19	Jan 28	Jan 18	Jan 20	Jan 19	Jan 25	Feb 2	NA
First symptom or sign	Fever	Fatigue	Cough	Fever	Fever	Fever	Cough	NA
Date of Confirmatory test done (SARS-CoV-2 quantitative RT-PCR)	Jan 25	Feb 4	Jan 22	Jan 26	Jan 21	Jan 29	Feb 5	NA
Complications
Respiratory failure	Yes	Yes	Yes	Yes	Yes	Yes	Yes	7 (100)
ARDS	Yes	Yes	Yes	Yes	Yes	Yes	Yes	7 (100)
Shock	Yes	Yes	Yes	Yes	No	No	No	4 (57·1)
Arrhythmia	No	Yes	No	Yes	Yes	Yes	No	4 (57·1)
Acute cardiac injury	No	Yes	Yes	Yes	No	No	Yes	4 (57·1)
Secondary infection	Yes	Yes	No	No	No	Yes	No	3 (42·9)
Acute kidney injury	Yes	Yes	No	No	No	No	No	2 (28·6)
Date of death	Jan 30	Feb 6	Jan 29	Jan 27	Jan 25	Feb 7	Feb 6	NA
First symptom to death, days	11	9	11	7	6	13	4	NA

Abbreviations: ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; NA, not applicable. *Exposure to Wuhan city where the epidemic is very serious in China.